Literature DB >> 7160420

Overdosage of antidepressants: clinical and pharmacokinetic aspects.

O L Pedersen, L F Gram, C B Kristensen, M Møller, P Thayssen, M Bjerre, P Kragh-SøRensen, N A Klitgaard, E Sindrup, P Hole, M Brinklø.   

Abstract

Twenty-nine cases of self-poisoning with antidepressants (amitriptyline, imipramine, clomipramine, maprotiline, doxepine, nortriptyline, opipramol) were examined by frequent observation of CNS effects, heart rate, blood pressure and standard ECG, 24h-ECG-monitoring, measurement of systolic time intervals, EEG recordings and frequent measurement of serum levels of antidepressants and primary metabolites. None of the patients died. Maximum total serum antidepressant level (parent compound + desmethyl metabolite) ranged from 20 to 2200 micrograms/l, with concentrations above 500 micrograms/l in 11 cases. The serum amitriptyline concentration remained high for 3-4 days in some of the severely intoxicated patients and the decay curves were compatible with partly saturated elimination. A degree of unconsciousness and the occurrence of excitation and hallucinations were generally seen in cases with total serum antidepressant levels above 500 micrograms/l. Grand mal seizures occurred more frequently at high antidepressant levels, but could not be predicted from the EEG recordings. Increased heart rate and prolonged QRS- and QTc-intervals were significantly correlated with the total serum antidepressant level. 24 h-ECG-monitoring revealed no serious arrhythmias or instances of heart block. Hypotension was only seen initially in few patients. Systolic time interval measurements showed changes suggesting impaired myocardial performance (elevated PEP/LVET ratio) at intermediate (60-500 micrograms/l) but not high (greater than 500 micrograms/l) total serum antidepressant levels. Measurement of serum concentration in antidepressant intoxication is important for identification of patients with high serum levels and the corresponding risk of developing toxic reactions, and to exclude patients with a low concentration who do not require intensive observation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7160420     DOI: 10.1007/bf00637499

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  26 in total

Review 1.  A review of the cardiovascular effects and toxicity of tricyclic antidepressants.

Authors:  J W Jefferson
Journal:  Psychosom Med       Date:  1975 Mar-Apr       Impact factor: 4.312

2.  Clinical features in poisonings by tricyclic antidepressants with special reference to the ECG.

Authors:  C Thorstrand
Journal:  Acta Med Scand       Date:  1976

3.  Prognosis after head injury based on early clinical examination.

Authors:  J Overgaard; O Hvid-Hansen; A M Land; K K Pedersen; S Christensen; J Haase; O Hein; W A Tweed
Journal:  Lancet       Date:  1973-09-22       Impact factor: 79.321

4.  Poisoning with tricyclic antidepressant drugs.

Authors:  A S Manoguerra
Journal:  Clin Toxicol       Date:  1977       Impact factor: 4.467

5.  Quantitative determination of imipramine and desipramine in human blood plasma by direct densitometry of thin-layer chromatograms.

Authors:  A Nagy; L Treiber
Journal:  J Pharm Pharmacol       Date:  1973-08       Impact factor: 3.765

6.  The toxicity of tricyclic antidepressants.

Authors:  D G Spiker
Journal:  Commun Psychopharmacol       Date:  1978

7.  Cardiovascular manifestations of tricyclic antidepressant overdose.

Authors:  R A Langou; C Van Dyke; S R Tahan; L S Cohen
Journal:  Am Heart J       Date:  1980-10       Impact factor: 4.749

8.  Tricyclic antidepressant overdose: incidence of symptoms.

Authors:  J T Biggs; D G Spiker; J M Petit; V E Ziegler
Journal:  JAMA       Date:  1977-07-11       Impact factor: 56.272

9.  Tricyclic antidepressants. Prolonged plasma levels after overdose.

Authors:  D G Spiker; J T Biggs
Journal:  JAMA       Date:  1976-10-11       Impact factor: 56.272

10.  Poisoning with tricyclic and related antidepressants--a ten-year review.

Authors:  I R Starkey; A A Lawson
Journal:  Q J Med       Date:  1980
View more
  9 in total

1.  Cardiotoxicity associated with an intentional overdose of maprotiline and perphenazine: a case report.

Authors:  D T Jolly; I G Stiell
Journal:  Can Fam Physician       Date:  1987-11       Impact factor: 3.275

2.  Prolonged toxicity after amitriptyline overdose in a patient deficient in CYP2D6 activity.

Authors:  Jennifer Cohen Smith; Steven C Curry
Journal:  J Med Toxicol       Date:  2011-09

3.  Suppression of plasma cortisol after oral administration of oxazepam in man.

Authors:  L F Gram; L Christensen; C B Kristensen; P Kragh-Sorensen
Journal:  Br J Clin Pharmacol       Date:  1984-02       Impact factor: 4.335

4.  Comparative animal studies on cardiovascular toxicity of tri- and tetracyclic antidepressants and citalopram; relation to drug plasma levels.

Authors:  V Boeck; A Jørgensen; K Fredricson Overø
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 5.  Poisoning due to tricyclic antidepressant overdosage. Clinical presentation and treatment.

Authors:  P Crome
Journal:  Med Toxicol       Date:  1986 Jul-Aug

Review 6.  Antidepressant toxicity and the need for identification and concentration monitoring in overdose.

Authors:  B M Power; L P Hackett; L J Dusci; K F Ilett
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

7.  Hexapropymate self-poisoning causes severe and long-lasting clinical symptoms.

Authors:  L L Gustafsson; A Berg; A Magnusson; H O Malmlund; B M Sandell; R Stig
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

8.  The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants.

Authors:  Pierre Baumann; Sven Ulrich; Gabriel Eckermann; Manfred Gerlach; Hans-Joachim Kuss; Gerd Laux; Bruno Müller-Oerlinghausen; Marie Luise Rao; Peter Riederer; Gerald Zernig; Christoph Hiemke
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

9.  Introduction of sustained release opipramol dihydrochloride matrix tablets as a new approach in the treatment of depressive disorders.

Authors:  Umit Gönüllü; Melike Uner; Gülgün Yener; Turan Altınkurt
Journal:  Int J Biomed Sci       Date:  2006-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.